Status:
RECRUITING
Protocol Active Surveillance Small Renal Masses (SRMs)
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Kidney Cancer
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Prospective study of active surveillance, non-randomized, multicentric, in asymptomatic patients over the age of 50 years, not affected by other tumors, with occasional diagnosis of single monolateral...
Eligibility Criteria
Inclusion
- ability to read, understand and interpret an informed consent;
- voluntary subscription of the active surveillance protocol through written informed consent; 3) age over 50 years;
- 4\) diagnosis of monolateral, monofocal, and first-rate solid renal mass less than 2 cm; 5) absence of symptoms due to renal tumor pathology.
Exclusion
- patients with a history of previous renal neoplasia;
- monorenal patients;
- patients with hereditary renal tumors (such as tuberous sclerosis and Von Hippel Lindau syndrome, etc.);
- patients with metastasis;
- patients suffering from immunodepressive diseases;
- patients on concomitant therapy with chemotherapeutic agents or systemic immunosuppressants;
- patients with life expectancy of less than 1 year.
Key Trial Info
Start Date :
April 29 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 11 2028
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03804320
Start Date
April 29 2015
End Date
December 11 2028
Last Update
February 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132